COVID-19 Impact

You may see some delays in posting new content due to COVID-19. If you have any questions, please submit a message to PSNet Support.

PSNet: Patient Safety Network
Journal Article

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review.

Phillips KA, Veenstra DL, Oren E, et al. JAMA. 2001;286:2270-9.

This study suggests that utilizing a patient’s genetic information to individualize medication treatments can help reduce adverse drug reactions.